Home page of The Cochrane Collaboration

Home

Cochrane Airways Group

Our reviews

We are in the process of updating our web-site - please bear with us!

Full list:

By subtopic:

Airways Group (317)
Chronic asthma - pharmacotherapy (81)
Beta-agonists, long-acting (11)
Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children
Addition of long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children
Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma
Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma
Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children
Long-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroid
Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma
Regular treatment with formoterol for chronic asthma: serious adverse events
Regular treatment with formoterol versus regular treatment with salmeterol for chronic asthma: serious adverse events
Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma
Regular treatment with salmeterol for chronic asthma: serious adverse events
Beta-agonists, short-acting (4)
Formoterol versus short-acting beta-agonists as relief medication for adults and children with asthma
Inhaled short acting beta2-agonist use in chronic asthma: regular versus as needed treatment
Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthma
Regular treatment with long acting beta agonists versus daily regular treatment with short acting beta agonists in adults and children with stable asthma
Phosphodiesterases (1)
Phosphodiasterase III inhibitors for chronic asthma (protocol stage)
Steroids, inhaled (18)
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children
Beclomethasone at different doses for chronic asthma
Beclomethasone for asthma in children: effects on linear growth
Beclomethasone versus budesonide for chronic asthma
Beclomethasone versus placebo for chronic asthma
Budesonide at different doses for chronic asthma
Budesonide versus placebo for chronic asthma in children and adults
Ciclesonide versus other inhaled steroids for chronic asthma in children and adults
Ciclesonide versus placebo for chronic asthma in adults and children
Fluticasone at different doses for chronic asthma in adults and children
Fluticasone versus 'extrafine' HFA-beclomethasone dipropionate for chronic asthma in adults and children
Fluticasone versus beclomethasone or budesonide for chronic asthma in adults and children
Fluticasone versus placebo for chronic asthma in adults and children
High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children
Holding chambers versus nebulisers for inhaled steroids in chronic asthma
Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease
Inhaled corticosteroids in children with persistent asthma: effects on growth (protocol stage)
Inhaled versus oral steroids for adults with chronic asthma
Steroids, oral (1)
Inhaled versus oral steroids for adults with chronic asthma
Steroids, intranasal (1)
Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis
Combination and additive therapies (13)
Addition of long-acting beta-agonists to inhaled corticosteroids for chronic asthma in children
Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children
Addition of long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma
Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma
Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children
Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children
Combination formoterol and inhaled steroid as maintenance and reliever therapy versus higher dose combination inhaler maintenance for chronic asthma in adults and children (protocol stage)
Combination formoterol and inhaled steroid versus beta-agonist as relief medication for chronic asthma in adults and children
Combined corticosteroid and long-acting beta-agonist in one inhaler for chronic asthma (protocol stage)
Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events
Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events
Antibiotics (1)
Macrolides for chronic asthma
Antihistamines (1)
Ketotifen alone or as additional medication for long-term control of asthma and wheeze in children
Antibodies and immunotherapy (2)
Anti-IgE for chronic asthma in adults and children
Injection allergen immunotherapy for asthma
Anticholinergics (2)
Anticholinergic agents for chronic asthma in adults
Anticholinergic therapy for chronic asthma in children over two years of age
Cardioselective beta-blockers (1)
Cardioselective beta-blockers for reversible airway disease
Cromones (3)
Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma
Inhaled sodium cromoglycate for asthma in children
Nedocromil sodium for chronic asthma in children
Gastro-oesophogeal reflux treatment (1)
Gastro-oesophageal reflux treatment for asthma in adults and children
Histamine antagonists (1)
Oxatomide for stable asthma in adults and children
Inhaler devices and delivery of therapy (3)
Holding chambers versus nebulisers for inhaled steroids in chronic asthma
Pressurised metered dose inhalers versus all other hand-held inhaler devices to deliver beta-2 agonist bronchodilators for non-acute asthma
Pressurised-metered dose inhalers versus other hand-held inhalation devices for the delivery of inhaled corticosteroid therapy in children with non-acute asthma (protocol stage)
Leukotriene antagonists (3)
Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma
Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children
Steroid sparing agents (10)
Anti-IgE for chronic asthma in adults and children
Azathioprine as an oral corticosteroid sparing agent for asthma
Chloroquine as a steroid sparing agent for asthma
Colchicine as an oral corticosteroid sparing agent for asthma
Cyclosporin as an oral corticosteroid sparing agent in stable asthma
Dapsone as an oral corticosteroid sparing agent for asthma
Gold as an oral corticosteroid sparing agent in stable asthma
Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children
Methotrexate as a steroid sparing agent for asthma in adults
Troleandomycin as an oral corticosteroid sparing agent in stable asthma
Vaccines (2)
Pneumococcal vaccine for asthma
Vaccines for preventing influenza in people with asthma
Xanthines (2)
Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma
Oral xanthines as maintenance treatment for asthma in children
Chronic asthma - non-pharmacotherapy (46)
Complementary therapies (6)
Acupuncture for chronic asthma
Buteyko breathing for asthma (protocol stage)
Herbal interventions for chronic asthma in adults and children
Homeopathy for chronic asthma
Manual therapy for asthma
Speleotherapy for asthma
Delivery of care (2)
Nurse versus physician led care for the management of asthma (protocol stage)
Primary care based clinics for asthma
Diet therapy and nutrition support (9)
Caffeine for asthma
Calorie controlled diet for chronic asthma
Cow's milk protein avoidance and development of childhood wheeze in children with a family history of atopy
Dietary marine fatty acids (fish oil) for asthma in adults and children
Dietary sodium manipulation and asthma
Monosodium glutamate avoidance for chronic asthma in adults and children (protocol stage)
Selenium supplementation for asthma
Tartrazine exclusion for allergic asthma
Vitamin C supplementation for asthma
Disease management and monitoring (9)
Asthma self management education with either regular healthcare professional review or written action plans or both in adults (protocol stage)
Culture-specific programs for children and adults from minority groups who have asthma
House dust mite control measures for asthma
Indigenous healthcare worker involvement for Indigenous adults and children with asthma
Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults
Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults
Telehealthcare for asthma
Written action plans for asthma in children
Written individualised management plans for asthma in children and adults
Education (10)
Asthma self management education with either regular healthcare professional review or written action plans or both in adults (protocol stage)
Culture-specific programs for children and adults from minority groups who have asthma
Education interventions for adults who attend the emergency room for acute asthma
Educational interventions for asthma in children
Home-based educational interventions for children with asthma
Interventions for educating children who are at risk of asthma-related emergency department attendance
Limited (information only) patient education programs for adults with asthma
Options for self-management education for adults with asthma
School-based self-management educational interventions for asthma in children and adolescents (protocol stage)
Self-management education and regular practitioner review for adults with asthma
Invasive therapeutic procedures (0)
Parasitology (0)
Psychotherapy (4)
Family therapy for asthma in children
Psychological interventions for adults with asthma
Psychological interventions for children with asthma
Written emotional disclosure for asthma (protocol stage)
Physical therapy (6)
Alexander technique for chronic asthma
Breathing exercises for asthma
Buteyko breathing for asthma (protocol stage)
Inspiratory muscle training for asthma
Manual therapy for asthma
Physical training for asthma
Acute asthma - pharmacotherapy (31)
Antibiotics (1)
Antibiotics for acute asthma
Anticholinergics (3)
Anticholinergic therapy for acute asthma in children (protocol stage)
Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children
Inhaled beta2-agonist and anticholinergic agents for emergency management of asthma in adults (protocol stage)
Epinephrine (0)
Leukotriene antagonists (1)
Leucotriene receptor antagonists in addition to usual care for acute asthma in adults and children (protocol stage)
Beta-agonists (9)
Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma
Combined inhaled anticholinergics and beta2-agonists for initial treatment of acute asthma in children
Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in children
Continuous versus intermittent beta-agonists for acute asthma
Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma
Inhaled beta2-agonist and anticholinergic agents for emergency management of asthma in adults (protocol stage)
Inhaled beta2-agonists for asthma in mechanically ventilated patients
Intravenous beta2-agonists for acute asthma in the emergency department
Oxygen versus air for nebulising beta-agonist bronchodilators in acute asthma (protocol stage)
Inhaler devices and delivery therapy (5)
Commercial versus home-made spacers in delivering bronchodilator therapy for acute therapy in children
Heliox for non-intubated acute asthma patients
Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma
Inhaled beta2-agonists for asthma in mechanically ventilated patients
Oxygen versus air for nebulising beta-agonist bronchodilators in acute asthma (protocol stage)
Magnesium sulfate (2)
Inhaled magnesium sulfate in the treatment of acute asthma
Magnesium sulfate for treating exacerbations of acute asthma in the emergency department
Other bronchodilators (1)
Ketamine for management of acute exacerbations of asthma in children (protocol stage)
Steroids, inhaled (3)
Early use of inhaled corticosteroids in the emergency department treatment of acute asthma
Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children
Inhaled steroids for acute asthma following emergency department discharge
Steroids, oral and systemic (4)
Corticosteroids for acute severe asthma in hospitalised patients
Corticosteroids for hospitalised children with acute asthma
Corticosteroids for preventing relapse following acute exacerbations of asthma
Early emergency department treatment of acute asthma with systemic corticosteroids
Xanthines (2)
Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma
Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators
Acute asthma - non-pharmacotherapy (3)
Ventilation (1)
Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma
Education (2)
Education interventions for adults who attend the emergency room for acute asthma
Interventions for educating children who are at risk of asthma-related emergency department attendance
Chronic Cough (12)
Antibiotics (1)
Antibiotics for prolonged moist cough in children
Anticholinergics (1)
Anticholinergics for prolonged non-specific cough in children
Antihistamines (1)
Anti-histamines for prolonged non-specific cough in children
Beta-agonists (0)
Cromones (1)
Inhaled cromones for prolonged non-specific cough in children
Delivery of care (1)
Clinical pathways for chronic cough in children
Environmental remediation and allergen reduction (1)
Indoor air modification interventions for prolonged non-specific cough in children
Gastro-oesophageal reflux treatment (1)
Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults
Leukotriene antagonists (1)
Leukotriene receptor antagonist for prolonged non-specific cough in children
Steroids (2)
Inhaled corticosteroids for non-specific chronic cough in children
Inhaled corticosteroids for subacute and chronic cough in adults (protocol stage)
Topical treatment (1)
Honey and lozenges for children with non-specific cough
Xanthines (1)
Methylxanthines for prolonged non-specific cough in children
Post-bronchiolitis cough (0)
Subacute cough (2)
Inhaled corticosteroids for sub-acute cough in children (protocol stage)
Inhaled corticosteroids for subacute and chronic cough in adults (protocol stage)
Exercise induced-bronchoconstriction (5)
Beta-2 agonists for exercise induced asthma (protocol stage)
Inhaled corticosteroids compared to placebo for prevention of exercise induced bronchoconstriction
Mast-cell stabilising agents to prevent exercise-induced bronchoconstriction
Nedocromil sodium for preventing exercise-induced bronchoconstriction
Nedocromil sodium versus sodium cromoglycate for preventing exercise-induced bronchoconstriction
Stable chronic obstructive pulmonary disease - pharmacotherapy (47)
Anticholinergics (11)
Combination inhaled steroid and long-acting beta-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease
Ipratropium bromide for stable chronic obstructive pulmonary disease (protocol stage)
Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease
Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease
Long-acting beta-agonist in addition to tiotropium versus either tiotropium or long-acting beta-agonist alone for chronic obstructive pulmonary disease (protocol stage)
The effect of adding inhaled corticosteroids to tiotropium and long-acting beta-agonists for chronic obstructive pulmonary disease
Tiotropium for stable chronic obstructive pulmonary disease
Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease (protocol stage)
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease (protocol stage)
Tiotropium versus placebo for chronic obstructive pulmonary disease (protocol stage)
Beta-agonists, long-acting (9)
Combination inhaled steroid and long-acting beta-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease
Inhaled corticosteroids versus long-acting beta-agonists for chronic obstructive pulmonary disease
Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease
Long-acting beta-agonist in addition to tiotropium versus either tiotropium or long-acting beta-agonist alone for chronic obstructive pulmonary disease (protocol stage)
Long-acting beta2-agonists for chronic obstructive pulmonary disease: serious adverse events (protocol stage)
Long-acting beta2-agonists for poorly reversible chronic obstructive pulmonary disease
The effect of adding inhaled corticosteroids to tiotropium and long-acting beta-agonists for chronic obstructive pulmonary disease
Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease (protocol stage)
Beta-agonists, short-acting (2)
Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease
Short-acting beta2-agonists for stable chronic obstructive pulmonary disease
Beta-agonists, ultra long-acting (0)
Steroids, inhaled (7)
Combination inhaled steroid and long-acting beta-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease
Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease
Inhaled corticosteroids for stable chronic obstructive pulmonary disease
Inhaled corticosteroids versus long-acting beta-agonists for chronic obstructive pulmonary disease
The effect of adding inhaled corticosteroids to tiotropium and long-acting beta-agonists for chronic obstructive pulmonary disease
Steroids, oral (1)
Oral corticosteroids for stable chronic obstructive pulmonary disease
Combination and additive therapies (9)
Combination inhaled steroid and long-acting beta-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease
Combination inhaled steroid and long-acting beta2-agonist versus tiotropium for chronic obstructive pulmonary disease
Combined corticosteroid and long-acting beta-agonist in one inhaler versus inhaled steroids for chronic obstructive pulmonary disease
Combined corticosteroid and long-acting beta-agonist in one inhaler versus long-acting beta-agonists for chronic obstructive pulmonary disease
Combined corticosteroid and long-acting beta-agonist in one inhaler versus placebo for chronic obstructive pulmonary disease
Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease
Ipratropium bromide versus short acting beta-2 agonists for stable chronic obstructive pulmonary disease
Long-acting beta-agonist in addition to tiotropium versus either tiotropium or long-acting beta-agonist alone for chronic obstructive pulmonary disease (protocol stage)
The effect of adding inhaled corticosteroids to tiotropium and long-acting beta-agonists for chronic obstructive pulmonary disease
Cardioselective beta-blockers (1)
Cardioselective beta-blockers for chronic obstructive pulmonary disease
Mucolytic agents (1)
Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease
Phosphodiesterases (1)
Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease
Antibiotics (1)
Prophylactic antibiotic therapy for chronic bronchitis
Vaccines (2)
Influenza vaccine for patients with chronic obstructive pulmonary disease
Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease
Delivery of inhaled therapy (1)
Pressurised metered-dose inhalers versus all other hand-held inhalers devices to deliver bronchodilators for chronic obstructive pulmonary disease
Xanthines (1)
Oral theophylline for chronic obstructive pulmonary disease
Stable chronic obstructive pulmonary disease - non-pharmacotherapy (24)
Complementary therapies (0)
Delivery of care (1)
Home care by outreach nursing for chronic obstructive pulmonary disease
Diet therapy and nutritional support (1)
Nutritional supplementation for stable chronic obstructive pulmonary disease
Education and disease management (4)
Integrated disease management interventions for patients with chronic obstructive pulmonary disease (protocol stage)
Interventions for adherence to pulmonary rehabilitation for chronic obstructive pulmonary disease (protocol stage)
Self-management education for patients with chronic obstructive pulmonary disease
Telehealthcare for chronic obstructive pulmonary disease
Oxygen therapy and ventilation (5)
Ambulatory oxygen for chronic obstructive pulmonary disease
Domiciliary oxygen for chronic obstructive pulmonary disease
Nocturnal non-invasive positive pressure ventilation for stable chronic obstructive pulmonary disease
Short-term ambulatory oxygen for chronic obstructive pulmonary disease
Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease
Physical therapy (11)
Airway clearance techniques for chronic obstructive pulmonary disease (protocol stage)
Breathing exercises for chronic obstructive pulmonary disease (protocol stage)
Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis
Inspiratory muscle training for chronic obstructive pulmonary disease (protocol stage)
Interventions for adherence to pulmonary rehabilitation for chronic obstructive pulmonary disease (protocol stage)
Maintenance rehabilitation for chronic obstructive pulmonary disease (protocol stage)
Non-invasive ventilation during exercise training for people with chronic obstructive pulmonary disease (protocol stage)
Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease (protocol stage)
Oxygen therapy during exercise training in chronic obstructive pulmonary disease
Pulmonary rehabilitation for chronic obstructive pulmonary disease
Water-based exercise training for chronic obstructive pulmonary disease (protocol stage)
Psychotherapy (0)
Smoking cessation (1)
Smoking cessation for chronic obstructive pulmonary disease
Surgery (1)
Lung volume reduction surgery for diffuse emphysema
Exacerbations of chronic obstructive pulmonary disease (15)
Anticholinergics (1)
Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
Beta-agonists (3)
Anticholinergic bronchodilators versus beta2-sympathomimetic agents for acute exacerbations of chronic obstructive pulmonary disease
Inhaled short-acting beta2-agonists versus ipratropium for acute exacerbations of chronic obstructive pulmonary disease
Methylxanthines for exacerbations of chronic obstructive pulmonary disease
Education and disease management (1)
Action plans with limited patient education only for exacerbations of chronic obstructive pulmonary disease
Steroids (2)
Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease
Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Pulmonary rehabilitation (1)
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease
Oxygen therapy and ventilation (3)
Heliox for treatment of exacerbations of chronic obstructive pulmonary disease
Non-invasive positive pressure ventilation for treatment of respiratory failure due to exacerbations of chronic obstructive pulmonary disease
Oxygen therapy in the pre-hospital setting for acute exacerbations of chronic obstructive pulmonary disease
Delivery of care (1)
Hospital at home for acute exacerbations of chronic obstructive pulmonary disease
Other (3)
Antibiotics for exacerbations of chronic obstructive pulmonary disease
Carbonic anhydrase inhibitors for hypercapnic ventilatory failure in chronic obstructive pulmonary disease
Doxapram for ventilatory failure due to exacerbations of chronic obstructive pulmonary disease
Allergic bronchopulmonary aspergillosis (1)
Azoles for allergic bronchopulmonary aspergillosis associated with asthma
Aspiration lung disease (1)
Restriction of oral intake of water for aspiration lung disease in children
Breathing dysregulation/hyperventilation syndrome (1)
Breathing exercises for dysfunctional breathing/hyperventilation syndrome in adults (protocol stage)
Bronchiectasis (20)
Airway clearance techniques for bronchiectasis (protocol stage)
Anticholinergic therapy for bronchiectasis
Bronchopulmonary hygiene physical therapy for chronic obstructive pulmonary disease and bronchiectasis
Influenza vaccine for children and adults with bronchiectasis
Inhaled hyperosmolar agents for bronchiectasis
Inhaled steroids for bronchiectasis
Leukotriene receptor antagonists for non-cystic fibrosis bronchiectasis
Long-acting beta2-agonists for bronchiectasis
Mucolytics for bronchiectasis
Nurse specialist care for bronchiectasis
Oral corticosteroids for bronchiectasis (stable and acute exacerbations)
Oral methylxanthines for bronchiectasis
Oral non steroid anti-inflammatories for children and adults with bronchiectasis
Physical training for bronchiectasis
Pneumococcal vaccines for children and adults with bronchiectasis
Prolonged antibiotics for purulent bronchiectasis in children and adults
Short acting beta2-agonists for bronchiectasis
Short courses of antibiotics for children and adults with bronchiectasis
Singing for children and adults with bronchiectasis
Surgery versus non-surgical treatment for bronchiectasis
Diagnostic test accuracy (1)
Galactomannan detection for invasive aspergillosis in immunocompromized patients
Idiopathic pulmonary fibrosis (2)
Corticosteroids for idiopathic pulmonary fibrosis
Non-steroid agents for idiopathic pulmonary fibrosis
Interstitial lung disease (3)
Domiciliary oxygen for interstitial lung disease
Nebulised morphine for severe interstitial lung disease
Physical training for interstitial lung disease
Pleural diseases (1)
Intra-pleural fibrinolytic therapy versus conservative management in the treatment of adult parapneumonic effusions and empyema
Post-extubation stridor (1)
Corticosteroids for the prevention and treatment of post-extubation stridor in neonates, children and adults
Primary tracheomalacia (1)
Interventions for primary (intrinsic) tracheomalacia in children
Sarcoidosis (2)
Corticosteroids for pulmonary sarcoidosis
Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis
Sleep apnoea (10)
Continuous positive airways pressure (4)
Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea
Continuous positive airways pressure for obstructive sleep apnoea in adults
Educational, supportive and behavioural interventions to improve usage of continuous positive airway pressure machines for adults with obstructive sleep apnoea
Pressure modification for improving usage of continuous positive airway pressure machines in adults with obstructive sleep apnoea
Oral appliance therapy (1)
Oral appliances for obstructive sleep apnoea
Drug treatment (2)
Anti-inflammatory medications for obstructive sleep apnea in children
Drug therapy for obstructive sleep apnoea in adults
Lifestyle modification (1)
Lifestyle modification for obstructive sleep apnoea
Surgery (2)
Adenotonsillectomy for obstructive sleep apnoea in children
Surgery for obstructive sleep apnoea in adults
Oxygen (0)
Pulmonary hypertension (3)
Endothelin receptor antagonists for pulmonary arterial hypertension
Phosphodiesterase five inhibitors for pulmonary hypertension
Prostacyclin for pulmonary hypertension in adults
Wheeze (4)
Anticholinergic drugs for wheeze in children under the age of two years
Inhaled steroids for episodic viral wheeze of childhood
Parent-initiated oral corticosteroid therapy for intermittent wheezing illnesses in children
Short acting beta2-agonists for recurrent wheeze in children under two years of age